Atrial fibrillation
CHA₂DS₂-VASc / CHA₂DS₂-VA
Stroke risk stratification in non-valvular AF. The 2024 ESC guideline uses CHA₂DS₂-VA (sex removed); both values are shown and the decision guide uses CHA₂DS₂-VA.
Upload a report, lab sheet or echo picture to fill this calculator automatically.
Age
Sex
Additional criteria
Tap every item that applies
- Female sex is a risk modifier rather than a risk factor; ESC 2024 removed it from the decision score.
Total 0 · CHA₂DS₂-VA 0
0
Low stroke risk
Annual stroke/TE ≈ 0–0.5% untreated
Decision guide
Oral anticoagulation not recommended. Reassess risk regularly (age, new comorbidities).
2 sections are still unanswered — counted as 0 points.
Ranges: 0 Low stroke risk1 Intermediate stroke risk2–9 High stroke risk
References
- Lip GYH, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in AF. Chest 2010;137:263-272.
- Van Gelder IC, et al. 2024 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2024;45:3314-3414.
- Joglar JA, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the diagnosis and management of atrial fibrillation. Circulation 2024;149:e1-e156.
More in Atrial fibrillation